Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea

Eui Soon Kim, Sun Kyeong Park, Daniel Sung ho Cho, Jong Chan Youn, Hye Sun Lee, Hae Young Lee, Hyun Jai Cho, Jin Oh Choi, Eun Seok Jeon, Sang Eun Lee, Min Seok Kim, Jae Joong Kim, Kyung Kuk Hwang, Myeong Chan Cho, Shung Chull Chae, Seok Min Kang, Jin Joo Park, Dong Ju Choi, Byung Su Yoo, Jae Yeong ChoKye Hun Kim, Byung Hee Oh, Barry Greenberg, Sang Hong Baek

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science